{
    "2018-07-20": [
        [
            {
                "time": "2018-07-13",
                "original_text": "Pfizer gets FDA approval for drug similar to Amgen's Neupogen",
                "features": {
                    "keywords": [
                        "FDA",
                        "approval",
                        "drug",
                        "Amgen",
                        "Neupogen"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-07-16",
                "original_text": "Top Research Reports for Microsoft, Novartis & Goldman Sachs",
                "features": {
                    "keywords": [
                        "research",
                        "reports",
                        "Microsoft",
                        "Novartis",
                        "Goldman Sachs"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "pharmaceuticals",
                        "finance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-17",
                "original_text": "Merck to Cut Price of Few Drugs Amid Drug Pricing Controversy",
                "features": {
                    "keywords": [
                        "Merck",
                        "price cut",
                        "drug pricing",
                        "controversy"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-07-18",
                "original_text": "Bullish Two Hundred Day Moving Average Cross - NVS",
                "features": {
                    "keywords": [
                        "bullish",
                        "moving average",
                        "cross",
                        "NVS"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-19",
                "original_text": "Swiss, German drugmakers join U.S. price freeze",
                "features": {
                    "keywords": [
                        "Swiss",
                        "German",
                        "drugmakers",
                        "price freeze",
                        "U.S."
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-07-20",
                "original_text": "Pharma Stock Roundup: JNJ & NVS' Q2 Earnings, FDA Approvals",
                "features": {
                    "keywords": [
                        "Pharma",
                        "Stock",
                        "Roundup",
                        "JNJ",
                        "NVS",
                        "Q2",
                        "Earnings",
                        "FDA",
                        "Approvals"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-21",
                "original_text": "The Swiss Stock Market Climbed Despite Trade Worries",
                "features": {
                    "keywords": [
                        "Swiss",
                        "Stock",
                        "Market",
                        "Climbed",
                        "Trade",
                        "Worries"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "general market"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-22",
                "original_text": "Three Key Takeaways From Healthcare Earnings Season",
                "features": {
                    "keywords": [
                        "Key",
                        "Takeaways",
                        "Healthcare",
                        "Earnings",
                        "Season"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-23",
                "original_text": "Free Post Earnings Research Report: Novartisâ€™ Net Sales Jumped 7%; Non-GAAP EPS Advanced 6%",
                "features": {
                    "keywords": [
                        "Post",
                        "Earnings",
                        "Research",
                        "Report",
                        "Novartis",
                        "Net",
                        "Sales",
                        "Non-GAAP",
                        "EPS"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-24",
                "original_text": "Valsartan Drugs Recalled Over Potential Carcinogen Contamination",
                "features": {
                    "keywords": [
                        "Valsartan",
                        "Drugs",
                        "Recalled",
                        "Potential",
                        "Carcinogen",
                        "Contamination"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-07-25",
                "original_text": "Novartis' (NVS) Kisqali Gets FDA Nod for Label Expansion",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Kisqali",
                        "FDA",
                        "Nod",
                        "Label",
                        "Expansion"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-26",
                "original_text": "Roche's Tecentriq Met Primary Goal in First-Line NSCLC Study",
                "features": {
                    "keywords": [
                        "Roche",
                        "Tecentriq",
                        "Primary",
                        "Goal",
                        "First-Line",
                        "NSCLC",
                        "Study"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}